• Home
• Key Data
• Bayer Stock
• Management Report
  • Overview of Sales, Earnings and Financial Position
  • Economic Outlook
  • Sales and Earnings Forecast
  • Corporate Structure
  • Performance by Subgroup, Segment and Region
    • HealthCare
    • CropScience
    • MaterialScience
    • Performance by Region
  • Calculation of EBIT(DA) Before Special Items
  • Core Earnings Per Share
  • Financial Position of the Bayer Group
  • Growth and Innovation
    • HealthCare
    • CropScience
    • MaterialScience
  • Employees
  • Opportunities and Risks
  • Events After the Reporting Period
• Financial Statements
  • Income Statements
  • Comprehensive Income
  • Financial Position
  • Statements of Cash Flows
  • Changes in Equity
  • Notes to the Condensed Consolidated
    • Key Data by Segment
    • Key Data by Region
    • Explanatory Notes
    • Responsibility Statement
    • Review Report
• Focus
• News
  • Overview
  • Further addition to crop protection portfolio
  • Expansion of Polymer Research & Development Center in Shanghai
  • Significant improvement in overall survival
  • German President praises Bayer’s innovations
  • U.S. approval for anticoagulant
  • VEGF Trap-Eye submitted for marketing authorizations
  • Licensing agreement for canola trait
  • Experiencing Bayer in social media
  • Improving wheat breeding
  • Cancer drug fast-tracked in the U.S.
  • New products for companion animals
  • Milestone in the battle against malaria
  • Raising awareness for sustainable construction
  • On a solar-powered journey
  • Initiative for children with burns injuries
  • Settlement in biotech rice litigation
• Services
  • Overview
  • Download Center

Print page

Download Center

Links

Publications

Services

Special Interest

• Investor Relations
• Press
• Jobs and Career
• Foundations
• Culture

• General Conditions of Use
• Privacy Statement
• Imprint
• Technical Details